BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 89 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,229,774 | +113979.2% | 263,900 | +24.1% | 0.00% | 0.0% |
| Q1 2024 | $1,078 | -14.8% | 212,600 | -52.8% | 0.00% | 0.0% |
| Q4 2023 | $1,266 | +34.1% | 450,400 | +36.9% | 0.00% | 0.0% |
| Q3 2023 | $944 | -15.3% | 328,900 | +49.0% | 0.00% | 0.0% |
| Q2 2023 | $1,115 | +171.3% | 220,700 | +1.5% | 0.00% | +100.0% |
| Q1 2023 | $411 | +3.5% | 217,500 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $397 | -99.9% | 220,613 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $368,000 | -45.0% | 217,700 | -20.0% | 0.00% | 0.0% |
| Q2 2022 | $669,000 | -8.7% | 272,002 | +2.8% | 0.00% | 0.0% |
| Q1 2022 | $733,000 | -64.3% | 264,491 | -31.4% | 0.00% | -66.7% |
| Q4 2021 | $2,054,000 | +355.4% | 385,400 | +1972.0% | 0.00% | +200.0% |
| Q1 2021 | $451,000 | -59.7% | 18,600 | -29.8% | 0.00% | 0.0% |
| Q2 2020 | $1,118,000 | – | 26,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,014,858 | $5,581,000 | 0.29% |
| NEA Management Company, LLC | 3,449,845 | $9,556,000 | 0.28% |
| Hawkeye Capital Management, LLC | 243,009 | $673,000 | 0.26% |
| DAFNA Capital Management LLC | 313,600 | $869,000 | 0.23% |
| Artal Group S.A. | 1,646,517 | $4,561,000 | 0.19% |
| MPM BioImpact LLC | 239,888 | $664,000 | 0.18% |
| RA Capital Management | 2,589,904 | $7,174,000 | 0.16% |
| Bellevue Group AG | 3,293,000 | $9,122,000 | 0.11% |
| Ikarian Capital, LLC | 159,390 | $441,000 | 0.06% |
| PDT Partners, LLC | 66,168 | $183,000 | 0.02% |